<DOC>
	<DOCNO>NCT02477059</DOCNO>
	<brief_summary>Hand osteoarthritis ( HOA ) affect interphalangeal joint metacarpophalangeal thumb common disease , prevalence 30 % population 70 . Some form HOA refractory usual treatment ( analgesic , NSAIDs , local injection ) lead high disability . In vitro vivo study show IL-6 involved OA process . The aim present study assess efficacy Interleukin-6-Receptor Inhibitor ( tocilizumab ) pain function patient refractory hand OA .</brief_summary>
	<brief_title>Effect Interleukin-6 Receptor Antagonist Tocilizumab Patients With Hand Osteoarthritis</brief_title>
	<detailed_description>Inclusion criterion : age 40 85 year ; HOA accord ACR criterion ; pain intensity least 40 ( VAS 0-100 ) ; least 3 painful joint within previous 3 month ; least 3 OA joint ( KL grade â‰¥ 2 ) ; failure respond full dose analgesic and/or NSAID . Exclusion criterion : history active inflammatory disease involve hand ; previous treatment TNF inhibitor ; history active chronic infection ; latent active tuberculosis . Patient randomize receive investigational product placebo week 0 week 4 ( 1:1 ) - arm 1 : 2 infusion four week apart tocilizumab 8mg/kg - arm 2 : 2 infusion four week apart saline solution Follow-up visit organize week 6 , week 8 week 12 . Primary outcome pain assess VAS week 6 . Secondary outcome include morning stiffness duration , patient practitioner global assessment , functional index hand OA , number painful joint , number swollen joint . 90 patient expect randomized 18 month . Each patient sign informed consent begin study .</detailed_description>
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<criteria>Age : 4085 Hand OA accord ACR criterion ( recent Xrays hand less 6 month ) Symptomatic hand OA last 3 month ( DIP PIP ) despite analgesic NSAIDs OA affect three finger joint ( DIP PIP ) ( Kellgren Lawrence equal 2 ) Pain intensity superior 40 ( VAS 0100 mm ) last 24 hour Not breastfeed throughout study 150 day last infusion Negative pregnancy test effective contraception woman childbearing age throughout study 150 day last infusion postmenopausal surgically sterile Written inform consent Affiliated health system Patients already treat antiTNF alpha within 6 month Patients already treat Interleukin6Receptor Inhibitor Hand OA secondary inflammatory rheumatism Existence painful syndrome upper limb likely interfere monitor pain ( cervicobrachial neuralgia , incapacitate carpal tunnel syndrome , joint disorder elbow shoulder ) Inflammatory rheumatism Psoriasis Contraindications Interleukin6Receptor Inhibitor Contraindications acetaminophen Anticoagulant ( oral ) treatment heparin curative dose Surgery schedule within 6 month follow recruitment Local injection corticosteroid symptomatic finger joint previous month Local injection hyaluronic acid symptomatic finger joint prior 6 month Treatment slowacting antiosteoarthritis agent initiate within previous 3 month Treatment methotrexate , hydrochloroquine , sulfasalazine , colchicine within last month History symptomatics sigmoiditis intestinal ulceration Oral corticosteroid within 3 day hydrocortisone cortisone , within 8 day prednisone , prednisolone , methylprednisolone triamcinolone , within 12 day betamethasone dexamethasone Psychiatric illness Antidepressants initiate modify within previous month Noncontrolled diabetes `` mellitus '' Known viral hepatitis B C , HIV infection Current infectious ( active latent tuberculosis ) Excessive drink Participation another search Lidocain plaster digital joint within two month</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Hand OA</keyword>
	<keyword>Tocilizumab</keyword>
	<keyword>Osteoarthritis</keyword>
	<keyword>Interleukin-6</keyword>
</DOC>